Litigation Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (Fed. Cir. 2022)
✉ Email this page to a colleague
United Therapeutics Corporation v. Liquidia Technologies, Inc. (Fed. Cir. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-08-18 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 9,604,901 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in United Therapeutics Corporation v. Liquidia Technologies, Inc.
Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (Fed. Cir. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-02-16 | 38 | cases in connection with the patent at issue (U.S. Patent No. 9,604,901) other than the matters noted…challenged the claims of UTC’s U.S. Patent No. 9,604,901 (“the ’901 patent”). Relevant to the Director’s intervention…Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in…Intellectual Property and Director of the United States Patent and Trademark Office, …proceedings brought by Liquidia against UTC’s ’901 patent (IPR2020-00770). In its final written decision, | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |